|
Systemic Lupus Erythematosus/sle
|
|
|
Systemic Lupus Erythematosus/sle Clinical Trials
- Prevention of Atherosclerosis and Heart Disease in Patients with Systemic Lupus Erythematosis (SLE)
ClinicalTrials.gov Identifier: NCT00054938 - Active, not recruiting
Systemic Lupus Erythematosus; Lupus
- Triptorelin for Ovary Protection in Childhood Onset Lupus
ClinicalTrials.gov Identifier: NCT00124514 - Recruiting
SLE; Systemic Lupus Erythematosus
- A Study to Evaluate the Efficacy and Safety of Rituximab in Patients with Severe Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov Identifier: NCT00137969 - Active, not recruiting
Lupus Erythematosus, Systemic
- A Study of Belimumab, a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov Identifier: NCT00410384 - Recruiting
Systemic Lupus Erythematosus
- A Study of Belimumab, a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov Identifier: NCT00424476 - Recruiting
Systemic Lupus Erythematosus
- Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
ClinicalTrials.gov Identifier: NCT00189124 - Recruiting
Systemic Lupus Erythematosus
- Treating Systemic Lupus Erythematosus (SLE) Patients with CTLA4-IgG4m (RG2077)
ClinicalTrials.gov Identifier: NCT00094380 - Active, not recruiting
Lupus Erythematosus, Systemic; Lupus Nephritis
- Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00076752 - Active, not recruiting
Lupus Erythematosus, Systemic
- Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov Identifier: NCT00418587 - Recruiting
Systemic Lupus Erythematosus
- Study of LymphoStat-B in Subjects with Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov Identifier: NCT00071487 - Completed
Lupus Erythematosus, Systemic
- GL701 (Prestara™) in Women with Systemic Lupus Erythematosus Receiving Treatment with Glucocorticoids
ClinicalTrials.gov Identifier: NCT00082511 - Active, not recruiting
Systemic Lupus Erythematosus
- Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination with Prednisone
ClinicalTrials.gov Identifier: NCT00119678 - Completed
Systemic Lupus Erythematosus
- Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov Identifier: NCT00172666 - Recruiting
Rheumatoid Arthritis; Systemic Lupus Erythematosus
- Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)
ClinicalTrials.gov Identifier: NCT00065806 - Active, not recruiting
Lupus Erythematosus, Systemic
- Monoclonal Antibody Treatment for Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00046774 - Active, not recruiting
Systemic Lupus Erythematosus
- Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
ClinicalTrials.gov Identifier: NCT00198068 - Recruiting
Systemic Lupus Erythematosus; Antiphospholipid Syndrome
- Role of altered CD40-Ligand gene transcription in systemic lupus erythematosus
ClinicalTrials.gov Identifier: NCT00008749 - Recruiting
Lupus Erythematosus, Systemic
- New Drug that may Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
ClinicalTrials.gov Identifier: NCT00088244 - Recruiting
Systemic Lupus Erythematosus; Lupus
- Study of GL701 in Men with Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00037128 - Active, not recruiting
Systemic Lupus Erythematosus
- Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
ClinicalTrials.gov Identifier: NCT00293072 - Completed
Systemic Lupus Erythematosus; ANCA Associated Vasculitis
- Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov Identifier: NCT00113971 - Terminated
Lupus Erythematosus, Systemic
- Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies
ClinicalTrials.gov Identifier: NCT00417430 - Active, not recruiting
Systemic Lupus Erythematosus
- HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00188357 - Recruiting
Systemic Lupus Erythematosus
- Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00017641 - Active, not recruiting
Systemic Lupus Erythematosus
- Physical Therapy for Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov Identifier: NCT00152555 - Terminated
Lupus Erythematosus, Systemic; SLE
- Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov Identifier: NCT00111306 - Terminated
Systemic Lupus Erythematosus
- Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture
ClinicalTrials.gov Identifier: NCT00006134 - Completed
Systemic Lupus Erythematosus
- A Study for Patients Previously Enrolled in Study U2971g to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00381810 - Active, not recruiting
Lupus Erythematosus, Systemic
- Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00325741 - Recruiting
Lupus Erythematosus, Systemic
- Study of LJP 394 in Lupus Patients with History of Renal Disease
ClinicalTrials.gov Identifier: NCT00089804 - Recruiting
Lupus Erythematosus, Systemic; Lupus Nephritis
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00000421 - Completed
Systemic Lupus Erythematosus
- Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00006133 - Completed
Systemic Lupus Erythematosus
- Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00479622 - Recruiting
Systemic Lupus Erythematosus
- Ultraviolet Light Therapy for Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00004375 - Recruiting
Systemic Lupus Erythematosus
- A Study of rhuMAb IFNalpha in Adults With Mildly Active Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00541749 - Recruiting
Systemic Lupus Erythematosus
- Humanized LL2IGG to Treat Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00011908 - Completed
Systemic Lupus Erythematosus
- An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00432354 - Recruiting
Systemic Lupus Erythematosus
- Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov Identifier: NCT00299819 - Completed
Lupus
- Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00004756 - Completed
Systemic Lupus Erythematosus
- Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov Identifier: NCT00383214 - Terminated
Systemic Lupus Erythematosus
- Cyclophosphamide and rATG/Rituximab in Patients With Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00278538 - Recruiting
Systemic Lupus Erythematosus
- Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00278590 - Recruiting
Systemic Lupus Erythematosus
- A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)
ClinicalTrials.gov Identifier: NCT00539838 - Not yet recruiting
Systemic Lupus Erythematosus
- Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00004663 - Completed
Systemic Lupus Erythematosus
- Role of Antibodies in Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00042523 - Completed
Systemic Lupus Erythematosus
- Can Targeted Elimination of B-Cell Depletion Therapy and/or Combination Therapy on SLE
ClinicalTrials.gov Identifier: NCT00556192 - Recruiting
Systemic Lupus Erythematosus
- The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS
ClinicalTrials.gov Identifier: NCT00413361 - Recruiting
Systemic Lupus Erythematosus
- Myfortic Versus Azathioprine in Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00504244 - Recruiting
Systemic Lupus Erythematosus
- Psychoeducational Approach to Improve Health in Lupus
ClinicalTrials.gov Identifier: NCT00000417 - Completed
Systemic Lupus Erythematosus
- Safety of Estrogens in Lupus: Birth Control Pills
ClinicalTrials.gov Identifier: NCT00000420 - Completed
Systemic Lupus Erythematosus
- Anti-CD20 in Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00036491 - Completed
Lupus Erythematosus, Systemic
- Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
ClinicalTrials.gov Identifier: NCT00342095 - Completed
Systemic Lupus Erythematosus
- Skin Denervation in Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00155532 - Completed
Systemic Lupus Erythematosus
- Low Dose Aspirin and Statins for Primary Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00371501 - Recruiting
Atherosclerosis; Thromboembolism; Systemic Lupus Erythematosus
- Genetic Studies of Lupus
ClinicalTrials.gov Identifier: NCT00071175 - Recruiting
Systemic Lupus Erythematosus
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women with Active Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00004662 - Completed
Systemic Lupus Erythematosus
- Lupus Atherosclerosis Prevention Study
ClinicalTrials.gov Identifier: NCT00120887 - Completed
Systemic Lupus Erythematosus
- High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide
ClinicalTrials.gov Identifier: NCT00005778 - Active, not recruiting
Lupus Erythematosus, Systemic
- Study of Epratuzumab in Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00383513 - Recruiting
Systemic Lupus Erythematosus
- Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease
ClinicalTrials.gov Identifier: NCT00188188 - Recruiting
Systemic Lupus Erythematosus
- Study of Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00001372 - Recruiting
Lupus Nephritis; Systemic Lupus Erythematosus
- Insulin Resistance and Atherosclerosis in a Sample of Women With Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00544102 - Recruiting
Systemic Lupus Erythematosus; Insulin Resistance; Atherosclerosis; Abnormal Glucose Metabolism; Cardiac Risk Factors
- Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
ClinicalTrials.gov Identifier: NCT00230035 - Recruiting
Systemic Lupus Erythematosus
- Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
ClinicalTrials.gov Identifier: NCT00271934 - Completed
Systemic Lupus Erythematosus
- Analyzing the Association of Gene Variants With Increased Risk of Coronary Heart Disease in Women With Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00563082 - Completed
Lupus Erythematosus, Systemic
- Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity
ClinicalTrials.gov Identifier: NCT00029926 - Completed
Lupus Erythematosus; Systemic
- Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women with Mild to Moderate Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00004795 - Completed
Systemic Lupus Erythematosus
- Safety of Estrogens in Lupus: Hormone Replacement Therapy
ClinicalTrials.gov Identifier: NCT00000419 - Terminated
Systemic Lupus Erythematosus
- Abnormalities of B Lymphocytes During Systemic Lupus
ClinicalTrials.gov Identifier: NCT00401141 - Recruiting
Systemic Lupus Erythematosus
- Duke Lupus Registry
ClinicalTrials.gov Identifier: NCT00512694 - Recruiting
Systemic Lupus Erythematosus; Cutaneous Lupus
- Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
ClinicalTrials.gov Identifier: NCT00010335 - Recruiting
Systemic Sclerosis; Systemic Lupus Erythematosus; Dermatomyositis; Juvenile Rheumatoid Arthritis; Autoimmune Diseases
- A Study to Evaluate the Safety and Effectiveness of Edratide in the Treatment of Lupus
ClinicalTrials.gov Identifier: NCT00203151 - Suspended
Systemic Lupus Erythematosus
- Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome
ClinicalTrials.gov Identifier: NCT00391924 - Completed
Lupus Erythematosus, Systemic; Sjogren's Syndrome
- The Research Registry for Neonatal Lupus
ClinicalTrials.gov Identifier: NCT00074373 - Recruiting
Neonatal lupus; Systemic Lupus Erythematosus; Sjogren's Syndrome; Congenital heart block
- Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00004643 - Completed
Lupus Erythematosus, Systemic
- Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00004665 - Completed
Systemic Lupus Erythematosus
- Genetic Study of Lupus Patients and Their Families
ClinicalTrials.gov Identifier: NCT00235378 - Recruiting
Systemic Lupus Erythematosus
- Memory and Attention Problems in Lupus: New Treatment Trial With Modafinil
ClinicalTrials.gov Identifier: NCT00297284 - Recruiting
Systemic Lupus Erythematosus
- Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
ClinicalTrials.gov Identifier: NCT00430677 - Recruiting
Systemic Lupus Erythematosus
- TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )
ClinicalTrials.gov Identifier: NCT00368264 - Recruiting
Lupus Erythematosus, Systemic; Lupus Nephritis
- Drug Therapy in Lupus Nephropathy
ClinicalTrials.gov Identifier: NCT00001212 - Completed
Nephrotic Syndrome; Systemic Lupus Erythematosus
- Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome
ClinicalTrials.gov Identifier: NCT00010400 - Completed
Systemic Lupus Erythematosus; Antiphospholipid Antibody Syndrome
- A Study to Evaluate the Safety and Tolerability of Multiple IV Doses of an Antibody, in Patients With Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00482989 - Recruiting
Lupus
- Cyclophosphamide in Lupus Nephritis
ClinicalTrials.gov Identifier: NCT00441220 - Recruiting
Systemic Lupus Erythematosus
- European Society of Cutaneous Lupus Erythematosus (EUSCLE)
ClinicalTrials.gov Identifier: NCT00420121 - Not yet recruiting
Systemic or Cutaneous Lupus Erythematosus
- Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
ClinicalTrials.gov Identifier: NCT00001676 - Completed
Glomerulonephritis; Lupus Nephritis; Systemic Lupus Erythematosus
- Study of Families with Twins or Siblings Discordant for Rheumatic Disorders
ClinicalTrials.gov Identifier: NCT00055055 - Recruiting
Rheumatic Diseases; Rheumatoid Arthritis; Systemic Lupus Erythematosus; Scleroderma; Dermatomyositis; Myositis
- Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-Like Receptors
ClinicalTrials.gov Identifier: NCT00519363 - Not yet recruiting
Systemic Lupus Erythematosus
- Phase IB, Multicenter, Randomized, Double-Blind Placebo-Controlled, Dose-Escalation Study w/Open-Label Extension to Evaluate Safety and Tolerability of Multiple IV Doses of MEDI-545; A Fully Human Anti-IFN-Alpha Monoclonal Antibody in Patients w/SLE
ClinicalTrials.gov Identifier: NCT00566163 - Recruiting
Systemic Lupus Erythematosus; Multiple Intravenous Doses; Pharmokinetics
- Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00582881 - Recruiting
Mixed Connective Tissue Disease; Systemic Lupus Erythematosus
- Safety and Efficacy Study of LJP 394 (abetimus sodium) to treat lupus kidney disease
ClinicalTrials.gov Identifier: NCT00035308 - Completed
Immunologic Diseases; Autoimmune Diseases; Systemic Lupus Erythematosus; Lupus Nephritis; Lupus Glomerulonephritis
- Six month clinical research study for patients with moderate or severe dry eye syndrome
ClinicalTrials.gov Identifier: NCT00025818 - Completed
Keratoconjunctivitis Sicca; Sjogren's Syndrome; Lupus Erythematosus, Systemic; Arthritis, Rheumatoid; Scleroderma, Systemic
- Memantine in Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00181298 - Not yet recruiting
Systemic Lupus Erythematosus
- Feasibility and Safety of Acupuncture for Systemic Lupus
ClinicalTrials.gov Identifier: NCT00493753 - Completed
Systemic Lupus Erythematosus
- Study of Methotrexate in Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00470522 - Completed
Systemic Lupus Erythematosus
- Estrogen and Gender Biased Autoimmunity
ClinicalTrials.gov Identifier: NCT00519454 - Recruiting
Systemic Lupus Erythematosus
- Duke Autoimmunity in Pregnancy Registry
ClinicalTrials.gov Identifier: NCT00513591 - Not yet recruiting
Pregnancy; Systemic Lupus Erythematosus; Cutaneous Lupus; Rheumatoid Arthritis; Sjogren's Syndrome; Scleroderma
- Pulse Corticosteroid Therapy and Effect on Brain Water Diffusivity
ClinicalTrials.gov Identifier: NCT00527176 - Recruiting
Systemic Lupus Erythematosus
- Health-Related Quality of Life Measure in Pediatric Lupus
ClinicalTrials.gov Identifier: NCT00280137 - Recruiting
Systemic Lupus Erythematosus; Quality of Life
- Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)
ClinicalTrials.gov Identifier: NCT00420173 - Recruiting
Cutaneous Lupus Erythematosus
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
